S
Susan K. Fautsch
Researcher at University of Minnesota
Publications - 9
Citations - 2024
Susan K. Fautsch is an academic researcher from University of Minnesota. The author has contributed to research in topics: Immunotherapy & Cell therapy. The author has an hindex of 8, co-authored 9 publications receiving 1815 citations.
Papers
More filters
Journal ArticleDOI
Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer.
Jeffrey S. Miller,Yvette Soignier,Angela Panoskaltsis-Mortari,Sarah A. McNearney,Gong H. Yun,Susan K. Fautsch,David H. McKenna,Chap T. Le,Todd E. DeFor,Linda J. Burns,Paul J. Orchard,Bruce R. Blazar,John E. Wagner,Arne Slungaard,Daniel J. Weisdorf,Ian J. Okazaki,Philip B. McGlave +16 more
TL;DR: It is suggested that haploidentical NK cells can persist and expand in vivo and may have a role in the treatment of selected malignancies used alone or as an adjunct to HCT.
Journal ArticleDOI
Adverse reactions in patients transfused with cryopreserved marrow
David F. Stroncek,Susan K. Fautsch,Larry C. Lasky,David D. Hurd,N. K. C. Ramsay,J. J. McCullough +5 more
TL;DR: This study suggests that the incidence of some reactions might be decreased by reducing the dose of DMSO transfused, and efforts should be made to improve marrow collection and processing techniques to minimize that risk.
Journal ArticleDOI
Good manufacturing practices production of natural killer cells for immunotherapy: a six‐year single‐institution experience
David H. McKenna,Darin Sumstad,Nancy Bostrom,Diane Kadidlo,Susan K. Fautsch,Sarah A. McNearney,Rose DeWaard,Philip B. McGlave,Daniel J. Weisdorf,John E. Wagner,Jeffrey McCullough,Jeffrey S. Miller +11 more
TL;DR: A report on the experience of clinical‐scale, good manufacturing practices (GMPs) production of NK cells to treat advanced cancer.
Journal ArticleDOI
Lymphodepletion followed by donor lymphocyte infusion (DLI) causes significantly more acute graft-versus-host disease than DLI alone
Jeffrey S. Miller,Daniel J. Weisdorf,Linda J. Burns,Arne Slungaard,John E. Wagner,Michael R. Verneris,Sarah Cooley,Rosanna Wangen,Susan K. Fautsch,Roby Nicklow,Todd E. DeFor,Bruce R. Blazar +11 more
TL;DR: Data suggest that chemotherapy-induced lymphodepletion enhances activation of donor lymphocytes, the toxicity needs to be managed before testing whether better disease control can be achieved.
Journal ArticleDOI
Diminished neo-antigen response to keyhole limpet hemocyanin (KLH) vaccines in patients after treatment with chemotherapy or hematopoietic cell transplantation
Jeffrey S. Miller,Julie M. Curtsinger,Melinda Berthold,Kirsten Malvey,Robin L. Bliss,Chap T. Le,Susan K. Fautsch,Arkadiusz Z. Dudek,Bruce R. Blazar,Angela Panoskaltsis-Mortari +9 more
TL;DR: KLH vaccines are safe and require only a single injection to test neo-antigen responses providing an optimal platform for definitive testing of strategies to improve diminished immune recovery after chemotherapy or post-HCT.